Only days after Moderna reported positive early results for its potential COVID-19 vaccine, AstraZeneca has stolen the spotlight back. On Thursday, the U.K. drug giant scored a $1.2 billion contribution from the United States for development, production and delivery of 300 million doses of its potential shot starting this fall. Source: Fierce Pharma 21/5/2020